These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19880338)

  • 61. [Haemovigilance in the health care establishment: its role in pediatric transfusion].
    Weiller J; Delbosc A; Greffier A
    Transfus Clin Biol; 2003 Oct; 10(5):353-62. PubMed ID: 14572551
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Changes in hospital human tissue oversight in the United States between 2005 and 2011: results of a follow-up AABB survey.
    Schlueter AJ; Whitaker BI; Gishta R; Malasky J; Josephson CD;
    Transfusion; 2014 Jan; 54(1):224-30. PubMed ID: 23672483
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Patient safety with blood products administration using wireless and bar-code technology.
    Porcella A; Walker K
    AMIA Annu Symp Proc; 2005; 2005():614-8. PubMed ID: 16779113
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Prospective study of the causes for destruction of labile blood products during 1999 at a University Hospital Center].
    Benz-Lemoine E; Baloge B; Dupuis M; Champagne X; Pradeau F; Redersdorff JC
    Transfus Clin Biol; 2001 Dec; 8(6):460-6. PubMed ID: 11802607
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A haemovigilance team provides both significant financial and quality benefits in a University Hospital.
    Decadt I; Costermans E; Van de Poel M; Kesteloot K; Devos T
    Transfus Apher Sci; 2017 Apr; 56(2):199-205. PubMed ID: 28027853
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Evolving Role of Information Technology in Haemovigilance Systems.
    Ramoa A; Condeço J; Escoval MA; Faber JC; Fdez-Riverola F; Lourenço A
    J Healthc Eng; 2018; 2018():6183468. PubMed ID: 29707185
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Computerization of hospital blood banks in France: what has been done and what remains to be done].
    Py JY; Schlanger S; Gorodetzky D; Lapègue R; Besse-Moreau M; Herr AL; Renaudier P; Daurat G; Breton P
    Transfus Clin Biol; 2012 Nov; 19(4-5):224-7. PubMed ID: 23039963
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Transfusion incidents related to bacterial contamination: review of the literature and hemovigilance data. For the working group Bacterial incidents of French Blood Agency, scientific advice of Bacthem and the French hemovigilance network].
    Perez P; Ngombet R; Debeir J; Noël L; Sari F
    Transfus Clin Biol; 1998 Jun; 5(3):203-10. PubMed ID: 9691364
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Computer-based hospital transfusion process: why and how does one establish a link between continuous quality improvement and clinical information system?].
    Staccini P; Quaranta JF; Hergon E; Joubert M; Fieschi M
    Transfus Clin Biol; 2000 Apr; 7(2):140-52. PubMed ID: 10812658
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Analysis of causes of destruction of labile blood products in health institutions: A multicentric study].
    Damais-Cepitelli A; Leo-Kodeli S; Lovi V; Gouëzec H; Lassale B; Augey L; Berger E; Betbèze V; Bourcier V; Daurat G; Ducroz S; Huchet C; Le Niger C; Pujol S; Puntous M;
    Transfus Clin Biol; 2018 Nov; 25(4):242-248. PubMed ID: 30145111
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [French European military haemovigilance guidelines].
    Sailliol A; Clavier B; Cap A; Ausset S
    Transfus Clin Biol; 2010 Dec; 17(5-6):315-7. PubMed ID: 21051263
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Evaluation of aa tracking system for labile blood products in the Midi-Pyrenes region].
    Verret C; Mathoulin-Pélissier S; Courbil R; Perez P; Destruel F; Roubinet F; Rech H; Vidal I; Salmi LR
    Transfus Clin Biol; 1998 Aug; 5(4):275-82. PubMed ID: 9789967
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Twenty-five years later: has ISBT 128 fulfilled its promise?
    Distler P; Ashford P
    Transfusion; 2019 Dec; 59(12):3776-3782. PubMed ID: 31565803
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Implementation and validation of a conceptual benchmarking framework for patient blood management.
    Kastner P; Breznik N; Gombotz H; Hofmann A; Schreier G
    Stud Health Technol Inform; 2015; 212():190-7. PubMed ID: 26063276
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Experiences with the electronic blood bank system at Oslo University Hospital Rikshospitalet].
    Solheim BG; Svennevig JL
    Tidsskr Nor Laegeforen; 2018 Nov; 138(19):. PubMed ID: 30497253
    [No Abstract]   [Full Text] [Related]  

  • 76. Developing EDI messages and supporting data models: a "bottom up" approach based on "single business purpose" messages meets user needs.
    Love BJ
    Medinfo; 1995; 8 Pt 1():212-5. PubMed ID: 8591156
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Regional procedure of blood products transport by emergency medical services].
    Lassale B; Fournier M; Dettori I; Aullen JP
    Transfus Clin Biol; 2012 Nov; 19(4-5):202-5. PubMed ID: 22885110
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Experience of the blood bank at the American University Hospital during the war in Lebanon.
    Allam CK; Alami SY
    Middle East J Anaesthesiol; 1978 Jun; 5(1):21-8. PubMed ID: 581686
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Electronic data interchange between Healthcare Establishments and French Blood Establishment].
    Quaranta JF; Staccini P; Casteuble J
    Transfus Clin Biol; 2003 Jun; 10(3):234-7. PubMed ID: 12798863
    [No Abstract]   [Full Text] [Related]  

  • 80. [Labile blood product traceability: definition, regulation, evaluation, and perspectives].
    Pélissier E; Nguyen L
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():72s-74s. PubMed ID: 10919229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.